Comparative Study of Prophylactic Agent for Venous Thromboembolism After Total Knee Arthroplasty
Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy of two prophylactic agent(aspirin
300mg/day and rivaroxaban 10mg/day) for venous thromboembolism after total knee arthroplasty.